Market Currents
Teva Pharmaceutical (TEVA) forecasts 2013 EPS of $4.85-$5.15 against Street expectations for...
-
Friday, November 30, 2012, 7:09 AM ETTeva Pharmaceutical (TEVA) forecasts 2013 EPS of $4.85-$5.15 against Street expectations for $5.63. Total revenue is expected at $19.5B-$20.5B. Shares -5.5% premarket. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments: